Search

Abstract: Europium doped gadolinium orthoborate nanorods and nanoribbons were morphology-controlled grown on the porous anodic aluminum oxide (AAO) template surface via a hydrothermal process combined with high-temperature calcination. The morphologies, crystal structures and luminescent properties of the as-prepared nanomaterials were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD) and photoluminescence (PL) spectra. The morphologies of the nanomaterials were controlled by the calcination temperature. If calcined at 1000°C, the morphology of the GdBO3:Eu3+ one-dimensional materials is nanorods; when calcined at 800 and 600°C, the shapes of the Eu-doped GdBO3 are nanoribbons. If treated at 900°C, the as-prepared samples are composed of nanorods and nanoribbons. The changed morphologies of the as-prepared nanomaterials obtained from different calcination temperatures were explained according to the structural phase transition of GdBO3. The PL spectrum shows that the characteristic emission of GdBO3:Eu3+ one-dimensional nanomaterials is the 5D0 → 7F1 transition. [Copyright &y& Elsevier]

Background and Purpose: Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnostic model that may distinguish TOS from ABC., Materials and Methods: We identified 51 cases of TOS treated at the First Affiliated Hospital of Sun Yat-Sen University from March 2001 to January 2016 and reviewed their records, imaging information and pathological studies. A diagnostic model was developed to differentiate TOS and ABC by Bayes discriminant analysis and was evaluated. The log-rank test was used to analyze the prognostic factors of TOS and to compare the outcome differences between TOS and other high-grade osteosarcoma subtypes., Results: The multi-disciplinary diagnostic method employed that combined clinical, imaging, and pathological studies enhanced the diagnostic accuracy. Age 18 years or younger and pathologic fracture were more common among the TOS patients than among the ABC patients (P = .004 and .005, respectively). The average white blood cell (WBC), platelet, lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) values of the TOS patients were higher than those of the ABC patients ( P = .002, .003, .007, and .007, respectively). Our diagnostic model, including the aforementioned factors, accurately predicted 62% and 78% of the TOS patients in the training and validation sets, respectively. The 5-year estimates of event-free survival and overall survival of the TOS patients were 52.5 ± 9.4% and 54.9 ± 8.8%, respectively, which were similar to those of patients with other osteosarcoma subtypes ( P = .950 and .615, respectively). Tumor volume and the LDH level were predictive prognostic factors ( P = .040 and .044) but not the presence of pathologic fracture or misdiagnosis ( P = .424 and .632, all respectively)., Conclusions: The multi-disciplinary diagnostic method and diagnostic model based on predictive factors, i.e. , age, the presence of pathologic fracture, and platelet, LDH, ALP and WBC levels, aided the differentiation of TOS and ABC. Smaller tumors and normal LDH levels were associated with better outcomes.